Gallbladder (GB) cancer (GBC) is a malignancy with a poor prognosis. The 5-year survival rate of unresected GBC is approximately 0%, and the 3-year survival rate of advanced GBC remains at <20% even after curative resection. 1,2 To improve the prognosis of GBC, proper diagnosis with imaging study is essential. Gallbladder cancer usually presents as a protruded lesion or wall thickening. However, some GB lesions, such as in the case of cholecystitis or adenomyomatosis, also present as a protrusion or wall thickening. This morphological similarity causes difficulties in the differentiation of benign from malignant GB lesions in imaging study. 3 To facilitate differentiation, various imaging studies have been